Global Hormone Replacement Therapy (HRT) Market 2021: Unmet Needs in Combination Therapies for HRT Drive Research for New Medicines –

Global Hormone Replacement Therapy (HRT) Market 2021: Unmet Needs in Combination Therapies for HRT Drive Research for New Medicines –

Global Hormone Replacement Therapy (HRT) Market 2021: Unmet Needs in Combination Therapies for HRT Drive Research for New Medicines –

DUBLIN–(BUSINESS WIRE)–The “Hormone Replacement Therapy (HRT) – Global Market Trajectory & Analytics” report has been added to’s offering.

Amid the COVID-19 crisis, the global market for Hormone Replacement Therapy (HRT) estimated at US$7.6 Billion in the year 2020, is projected to reach a revised size of US$10.6 Billion by 2027, growing at a CAGR of 4.8% over the period 2020-2027.

The U.S. Market is Estimated at $2.2 Billion, While China is Forecast to Grow at 4.6% CAGR

The Hormone Replacement Therapy (HRT) market in the U.S. is estimated at US$2.2 Billion in the year 2020. China, the world’s second largest economy, is forecast to reach a projected market size of US$1.9 Billion by the year 2027 trailing a CAGR of 4.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.5% and 4.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.

Select Competitors (Total 31 Featured):

  • Abbott Laboratories
  • Allergan Plc
  • Bayer AG
  • Novartis AG
  • Noven Pharmaceuticals Inc.
  • Novo Nordisk A/S
  • Pfizer Inc.
  • TherapeuticsMD Inc.

Key Topics Covered:




  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • An Introduction to Menopause and Hormone Replacement Therapy
  • Recent Market Activity
  • The HRT Controversy – An Insight
  • Newer Studies Challenge WHI Findings and Re-establish Safety of HRT
  • Revised Recommendations of the NAMS and Endocrine Society
  • IMS Consensus Guidelines Paving Way for More Clarity of HRT
  • The Regional Divide
  • Increasing Number of Menopausal Women – A Major Market Driver
  • New Bioidentical Drugs Serve Unmet Market Needs
  • Generic Incursion in Hormone Replacement Therapy – List of Drugs With and Without Approved Generic Versions
  • Intense Competition Marks the Global HRT Market
  • The Premarin Saga
  • Estrace Cream Drives Revenue Gains in Allergan’s HRT Portfolio



  • Unmet Needs in Combination Therapies for HRT drive Research for New Medicines
  • Topical Estrogens – More Safe and Effective
  • Transdermal HRT Products Present Exciting Opportunities
  • Phytoestrogens – The New Panacea for Menopausal Symptoms?
  • Diet Link to Menopause Symptoms Raises Interest
  • Impact of Soy and Other Phytoestrogens – A Reality Check
  • EstroG – A Successful Herbal Health Supplement in Alleviating Menopausal Symptoms
  • The Growing Buzz around Bioidentical Drugs
  • Bio-identical Hormones – A Natural and Safe Substitute to Synthetic HRT?
  • Pellet Therapy – A New Innovation Downsizes Conventional Issues with Bioidentical HRT
  • Direct-to-Consumer Advertising for HRT – A Mixed Bag
  • Estriol: The Next Generation Estrogen Therapy?
  • What Makes Estriol Work?
  • Topical Estriol – More Promising in Safety
  • Estriol – Used More Commonly Outside the US
  • Entry of Generics Threatens Market Growth Prospects
  • Are Non-Hormonal Therapies A Threat to HRT?
  • Earlier Failures Induce Lethargy in Non-Hormonal Therapies




For more information about this report visit

About is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900